摘要
目的 探讨2型糖尿病肾病患者尿β2微球蛋白(U-β2-MG)的相关因素及临床意义。方法 收集DN患者171例,并分析U-β2-MG与临床各观察指标的相关性。进一步将患者分为单纯糖尿病、糖尿病合并高血压病、糖尿病合并高血压和高脂血症三组再进行相关分析。结果 整体来看,U-β2-MG与A1b、IgG、α1-MG、SBP、SCr显著相关,与DM病史、DBP、BUN、UA无明显相关性。在单纯糖尿病组,U-β2-MG与CHO、HDL-C、SCr、BUN显著相关,与GFR负相关,与SBP、DBP、TG、 LDL-C、SCr、BUN、UA无明显相关性;在糖尿病合并高血压病组,U-β2-MG与SBP、CHO、LDL-C、SCr显著相关,与GFR负相关,与DBP、TG、HDL-C、BUN、UA无明显相关性;在糖尿病合并高血压和高脂血症组,U-β2-MG与各临床指标无相关性。结论 DN较普遍地存在肾小管间质受损,U-β2-MG与GFR呈明显负相关,表明GFR轻度下降时,U-β2-MG已有增高;U-β2-MG与CHO、LDL-C、SCr显著相关,表明早期积极控制血脂变化对DN预后,特别是避免肾小管损害有重要意义。
Abstract
Objective To discuss the clinical implications of urinary β2 microglobulin(U-β2-MG)and its related factors in T2 Diabetes Mellitus patients with diabetic nephropathy(DN). Methods We collected 171 diagnosed DN patients (male 109, female 62). Correlation analysis of U-β2-MG and the other clinical test items was made. Correlation analysis was made again after we divided patients into three groups: simple DM , DM with hypertension, DM with hypertension and hyperlipidemia. Results Positive correlation between levels of U-β2-MG and indices as A1β, IgG, a1-MG, level of SCr and SBP was found. Within group DM, levels of U-β2-MG had an significantly positive correlation with levels of CHO、HDL、BUN, while showing negative correlation with GFR. In the group of DM with hypertension, there was a positive correlation with levels of U-β2-MG and those of SBP,CHO,LDL,SCr, and a negative correlation with GFR . In the last group, there was an significantly positive correlation between levels of U-β2-MG and DBP,LDL,BUN,and still a negative correlation with level of U-β2-MG and GFR. Conclusions Damage of Tubule interstitial is easily found in DN patients. U-β2-MG was negatively correlated with GFR, indicating that U-β2-MG has already increased when GFR slightly decreased. The produce of U-β2-MG is closely related to the level of blood glucose ,blood pressure, and lipid level. U-β2-MG was significantly associated with CHO, LDL-C, SCr, which showed that early active control of blood lipid might have positive effects on the prognosis of DN, especially in aspect of avoiding renal tubular damage.
关键词
2型糖尿病肾病 /
肾小管 /
相关分析
Key words
type 2 diabetic nephropathy /
kidney tubule /
relevant analysis
贾晓炜,栾 进,张南雁,李 岚,赵 琳,贾贺堂.
2型糖尿病肾病患者肾小管功能相关因素分析[J]. 武警医学. 2013, 24(5): 387-389
JIA Xiaowei,LUAN Jin,ZHANG Nanyan,LI Lan,ZHAO Lin,and JIA Hetang.
In patients with type 2 diabetes kidney disease clinical factors associated with renal tubular function analysis[J]. Medical Journal of the Chinese People Armed Police Forces. 2013, 24(5): 387-389
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 周建光,杨 梅.尿微量白蛋白的临床检验意义及诊断价值[J].实用医技杂志,2008,15(5):578.
[2] Alexopoulos E,Papagianni A,Papadimitriou M.Is membranous nephropathy only a glomerular disease[J].Renal Failure,1998,2O(1):1-6.
[3] Risdon R A,Sloper J C,DeWardener H E.Relationship between renal function and histological changes found in renalbiopsy specimens from Patients with persistent glomerular nephritis[J].Lancet,1968,7564(2):363-366.
[4] 孙 伟,曾安平,王 钢,等.肾小管间质病变与进行性肾小球损害[J].医学综述,1998,4(10):532-535.
[5] Vangelista A ,Frasca G M ,Severi Β,et al.Clinical factors in progressive renal damage:the role of interstitial fibrosis[J].Am J Kidney Dis,1991,17(5):62-64.
[6] Mogensen C E,Risdon R A.Natural history of renal functional abnormalities in human diabetes mellitus[M].The Kidney in diabetes mellitus.New York Livingstone,1989:19.
[7] Remuzzi G,Bertani T.Pathophysiology of progressive nephropathies[J].N Engl J Med,1998,339(20):1448.
[8] 刘 红,邢淑清,赵红娟,等.尿N-乙酰-β-D-氨基葡萄糖苷酶、尿微量白蛋白、尿β2-微球蛋白、尿α1-微量球蛋白检测对糖尿病肾病的早期诊断价值及临床意义[J].中国临床实用医学,2010,4(4):93-94.
[9] 梅长林,徐洪实.血尿-微球蛋白测定的临床意义及其评价[J].中国实用内科杂志,1999, 19(4): 200-201.
